Knowledge Base

Why is it important to strictly follow the protocol of clinical trials?

10 January 2024
2 min read

The violation of the requirements of the test plan during the test will cause many problems: the management authority will measure the current situation of the quality of the test and the research base according to the violation of the test plan during the inspection; A trial protocol that violates the approval of the ethics committee is a violation of the approval of the Ethics Committee (sometimes the regulatory authority); Subjects who are not enrolled according to the enrollment / exclusion criteria may not be compensated by the sponsor in case of damage; Subjects not enrolled according to the test plan may increase the deviation of the test results and make the test unable to achieve the purpose of the peak period; The test cannot provide valid data or results; Sometimes, the sponsor will impose financial penalties on researchers who violate the trial plan, such as refusing to pay the trial funds for the number of subjects who fail to enroll as required. In the past, researchers could destroy the old version of the trial protocol. But now the new regulation stresses that the old version of the test documents should be kept and indicated with expiration date. Or use different color covers to distinguish the old version from the new version, and place the expired documents elsewhere to prevent confusion.

Avenzo Therapeutics unveils promising CDK2 inhibitor AVZO-021, originally from Allorion Therapeutics
Latest Hotspot
3 min read
Avenzo Therapeutics unveils promising CDK2 inhibitor AVZO-021, originally from Allorion Therapeutics
10 January 2024
Avenzo Therapeutics has disclosed the promising clinical phase CDK2 inhibitor known as AVZO-021, originally developed by Allorion Therapeutics.
Read →
Who should be responsible for the statistical analysis of clinical trials?
Knowledge Base
2 min read
Who should be responsible for the statistical analysis of clinical trials?
10 January 2024
Upon trial completion, the supervisor will retrieve the original case report form's first page, followed by data entry into the database for statistical analysis by the biostatistician per the pre-trial plan.
Read →
Inspirna partners with German Merck KGaA to accelerate global development of RGX-202, also called Ompenaclid
Latest Hotspot
4 min read
Inspirna partners with German Merck KGaA to accelerate global development of RGX-202, also called Ompenaclid
9 January 2024
Inspirna teams up with German-based Merck KGaA to expedite the worldwide advancement of the drug Ompenaclid, known as RGX-202
Read →
TLR9 agonists: What They Are and How to Stay Updated on the Latest Research
TLR9 agonists: What They Are and How to Stay Updated on the Latest Research
9 January 2024
TLR9 agonists are molecules that activate the Toll-like receptor 9, enhancing immune response against microbial infections.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.